Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

NeuroMetrix Inc (NURO)

  • Technical Exchange News
  • May 02, 2025, 07:56 UTC
  • 46
  • 0 comments

NeuroMetrix Inc (NURO) was removed from the list of traded instruments on NASDAQ exchange

Comment Full text

Universe Pharmaceuticals Inc. (UPC)

  • Technical Exchange News
  • May 02, 2025, 01:35 UTC
  • 47
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient and Delinquent. New value: Delinquent.

Comment Full text

Qualigen Therapeutics Inc. (QLGN)

  • Technical Exchange News
  • May 02, 2025, 01:35 UTC
  • 48
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Deficient and Delinquent.

Comment Full text

Onconetix, Inc. (ONCO)

  • Technical Exchange News
  • May 02, 2025, 01:35 UTC
  • 44
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Deficient and Delinquent.

Comment Full text

NeuroMetrix Inc (NURO)

  • Technical Exchange News
  • May 02, 2025, 00:39 UTC
  • 42
  • 0 comments

NASDAQ traded attribute type Security_Name was changed. Previous value: NeuroMetrix, Inc. - Common Stock. New value: NeuroMetrix, Inc. - Common Stock.

Comment Full text

NeuroMetrix Inc (NURO)

  • Technical Exchange News
  • May 02, 2025, 00:39 UTC
  • 43
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: N. New value: NeuroMetrix, Inc. - Common Stock.

Comment Full text

NeuroMetrix Inc (NURO)

  • Technical Exchange News
  • May 02, 2025, 00:39 UTC
  • 43
  • 0 comments

NASDAQ traded attribute type Test_mode was changed. Previous value: N. New value: NeuroMetrix, Inc. - Common Stock.

Comment Full text

Universe Pharmaceuticals Inc. (UPC)

  • Technical Exchange News
  • May 01, 2025, 19:30 UTC
  • 39
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient and Delinquent. New value: Delinquent.

Comment Full text

Qualigen Therapeutics Inc. (QLGN)

  • Technical Exchange News
  • May 01, 2025, 19:30 UTC
  • 39
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Deficient and Delinquent.

Comment Full text

Onconetix, Inc. (ONCO)

  • Technical Exchange News
  • May 01, 2025, 19:30 UTC
  • 37
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Deficient and Delinquent.

Comment Full text
  • Previous
  • 188
  • 189
  • 190
  • 191
  • 192
  • Next

Search

News categories

  • Technical Exchange News(10894)
  • Event(2282)
  • SEC News(189780)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(124696)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin